In a significant leap forward, Parx Materials' groundbreaking technology has achieved a critical certification, making it a game-changer in ensuring clean and safe drinking water delivery.

Parx Materials N.V. published the agenda and other meeting documents for its Annual General Meeting (AGM). The AGM will be held on May 19, 2023 in Rotterdam, The Netherands.

Global Health & Pharma Magazine has recently awarded Parx Materials the title: Most Sustainable Antimicrobial Technology Company 2022 - Europe. GHP will publish more on the awards December 2022.

Zinc Pyrithione is no longer permitted in plastics, industrial products, or cosmetics in the EU. Zinc Pyrithione has been the number one anti-dandruff ingredient. Parx Materials now offers a bio-derived, 100% safe, non-toxic replacement that proves to be 100% effective in clinical trials.

Parx Materials announces successful clinical trial using the company’s technology in vaginal gel and foam for the treatment of vaginal human papillomavirus (HPV) infections.

Facemasks made from fabric or non-woven produced with Parx Materials Saniconcentrate. Some of the performance measured by independent laboratories, such as SGS: 99,9% effective against SARS-CoV-2 in 2(!) hours, 99,99% effective against H1N1 in 8 hours and >99% effective against bacteria.

New test results demonstrate Saniconcentrate™ can withstand over 1,000 cycles in the dishwasher across a period of four years. The result of the durability test is a breakthrough for touch surfaces in food contact applications. In contrast to existing antimicrobial technologies, Saniconcentrate offers vastly superior durability without biocides, leaching, or harmful side effects.

While antibiotic-resistant super bacteria make headlines, it’s super fungi that could be the next big danger to human health. Candida auris is one example, as it is multidrug-resistant and can persist on surfaces, despite disinfection. However, Saniconcentrate™ by Parx Materials, protects surfaces and equipment against Candida auris with an efficacy of 87% in 24 hours.

Two experiments with fresh milk we would like to share with you. Keeping milk fresher for longer….

Parx Materials N.V. published the agenda and other meeting documents for its Annual General Meeting (AGM). The AGM will be held on June 3, 2021 at Goudsesingel 96, 3011 KD Rotterdam.

Parx Materials N.V. additive PEU-UNI007 Saniconcentrate™ was selected by vehicle equipment and components manufacturer, Ruspa Officine Spa for new certified vehicle components with antiviral properties.

Parx Materials N.V., a materials innovation company, today announced that the Brazilian Patent Office has granted a patent application related to the Company's method for inhibiting bacteria attachment and formation of biofilms. The notice of allowance was issued on April 13, 2021.

Dame: a "period product for the 21st-century". A reusable, self-cleaning tampon applicator designed to offer women a more sustainable alternative to the currently disposable counterparts. From successful Kickstarter campaign to world-wide recognised product.

New test results demonstrate Saniconcentrate™, an additive technology patented by Parx Materials, reduces Covid-19 virus on surfaces by up to 99% in 24 hours. Unlike other antimicrobial options, it achieves this without biocides, leaching or harmful side effects, creating a breakthrough option for applications like touch surfaces in public areas, medical devices or food contact applications.

WIRED JAPAN features Parx Materials N.V. in the special publication: FOOD re-generative. A terribly beautiful publication on innovations and developments related to food, food production and food preservation.

With the new year, we are starting with new packaging for the 20kg packaging of Saniconcentrate™. We are now using a reusable and recyclable drum. The drum is made out of 3 materials which can easily be dissembled without using any tools.

Zwiers Regulatory Consultancy finalised its evaluation of the compliance of Saniconcentrate™ in food contact applications according to EU and US regulations.

Now SGS also confirmed that the material has antiviral properties against Influenza-A virus H3N and reduces this virus by 98.06% in 2 hours following the ISO 18184:2014 testing protocol. This is on top of to the proven efficacy against: Corona 229E virus and H1N1 virus.

Zwiers Regulatory Consultancy finalized its evaluation of the safety of the Parx Materials technology in medical devices according to the applicable standards (ISO 10993) and Regulation (EC) No 1907/2006. The outcome was that the starting and reaction materials applied are well-known and can be used to further process as part of a medical device.

Current anti-odor technologies are using migrating technologies, having a biocide leach out of the garment to kill odor-causing bacteria. These solutions wash out in the washing machine and contaminate our oceans and environment. The Parx technology is biocompatible and does not wash out and improvement of medical skin conditions are reported by users.